课题基金 / 基金详情

URSODEOXYCHOLATE/METHOTREXATE FOR TREATMENT OF PRIMARY BILIARY CIRRHOSIS

URSODEOXYCHOLATE/METHOTREXATE FOR TREATMENT OF PRIMARY BILIARY CIRRHOSIS
熊去氧胆酸盐/甲氨蝶呤治疗原发性胆汁性肝硬化
批准号：
5220248
负责人：
KENT G BENNER
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5220248
关键词：
biliary tract disorder chemotherapy clinical research clinical trials combination chemotherapy drug screening /evaluation human subject human therapy evaluation longitudinal human study methotrexate primary biliary cirrhosis ursodeoxycholate

项目摘要

项目成果

KENT G BENNER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a multicenter, NIH-sponsored treatment trial of ursodeoxycholate (UDCA) plus methotrexate (MTX) or placebo in the treatment of primary biliary cirrhosis. Patients will be followed for six years on combined therapy. The endpoints of the study will be patient well-being, laboratory parameters, evidence of hepatic decompensation, histologic changes, need for liver transplantation, survival, and toxicity and safety.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
URSODEOXYCHOLATE-METHOTREXATE FOR TREATMENT OF PRIMARY BILIARY CIRRHOSIS
Ursodeoxycholate-Methotrexate for Treatment of Primary Biliary Cirrhosis
NORTH AMERICAN STUDY OF TREATMENT FOR REFRACTORY ASCITES (NASTRA)
Study of sandostatin LAR in patients with cirrhosis
海外基金